MÜDERRİSOĞLU, A. Et Al. 2018. EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.123 , 6.

MÜDERRİSOĞLU, A., Babaoglu, E., KORKMAZ, E., Ongun, M. C., KARABULUT, E., Emri, S., ... BABAOĞLU, M. Ö.(2018). EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.123, 6.

MÜDERRİSOĞLU, AHMET Et Al. "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.123, 6, 2018

MÜDERRİSOĞLU, AHMET Et Al. "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.123, pp.6, 2018

MÜDERRİSOĞLU, A. Et Al. (2018) . "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.123, p.6.

@article{article, author={AHMET MÜDERRİSOĞLU Et Al. }, title={EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2018, pages={6} }